Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Www.biospace.com save search
Evommune Announces Appointment of Kyle Carver as Chief Financial Officer
Published: 2022-03-22 (Crawled : 13:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
Aytu BioPharma to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
Published: 2022-03-22 (Crawled : 13:00) - biospace.com/
AYTU | $2.73 -2.84% -2.92% 9.1K
|
Health Technology
|
| O: 0.0%
H: 3.57%
C: 1.79%
biopharma rare disease
ENDRA Life Sciences to Report Fourth Quarter 2021 Financial Results on March 30, 2022
Published: 2022-03-22 (Crawled : 13:00) - biospace.com/
NDRA | $0.248 -0.88% -0.89% 37K
|
Health Technology
|
| O: 2.11%
H: 2.53%
C: -2.06%
report results
CENTENE CORPORATION SCHEDULES 2022 FIRST QUARTER FINANCIAL RESULTS CONFERENCE CALL
Published: 2022-03-22 (Crawled : 13:00) - biospace.com/
CNC | $75.84 0.34% 0.0% 1.7M
|
Health Services
|
| O: 0.56%
H: 1.0%
C: 0.38%
conference corporation results
Scholar Rock Presents Data Analysis of Multiple Efficacy Endpoints from the Apitegromab TOPAZ Phase 2 Trial at the American Academy of Neurology 2022 Annual Meeting
Published: 2022-03-22 (Crawled : 12:30) - biospace.com/
SRRK 4 | $14.79 5.64% 5.34% 740K
|
Health Technology
|
| O: 0.99%
H: 8.51%
C: 6.3%
trial phase 2
Edesa Biotech Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Published: 2022-03-22 (Crawled : 12:30) - biospace.com/
EDSA | $4.38 0.22% 2.3K
|
Health Technology
|
| O: -15.17%
H: 10.56%
C: 2.42%
offering nasdaq biotech
KalVista Announces Publication of Additional KVD900 Data in Clinical & Experimental Allergy
Published: 2022-03-22 (Crawled : 12:30) - biospace.com/
KALV | News | $11.21 -2.01% -2.05% 190K
|
Health Technology
|
| O: 0.86%
H: 7.97%
C: 7.57%
kvd900
Plus Therapeutics Announces First Patient Dosed in Phase 1/2a Dose Escalation Trial of 186RNL Radiotherapeutic for Leptomeningeal Metastases
Published: 2022-03-22 (Crawled : 12:30) - biospace.com/
PSTV | News | $1.65 -0.6% -0.61% 17K
|
Health Technology
|
| O: -0.99%
H: 10.0%
C: 0.0%
trial therapeutics phase 1
Blue Water Vaccines Announces Publication in Nano Research Supporting Novel S&P Vaccine Platform Versatility
Published: 2022-03-22 (Crawled : 12:30) - biospace.com/
BWV | $0.1802 5.44% 530K
|
|
| O: -6.29%
H: 18.09%
C: 18.09%
research blue vaccine platform
Ecolab Celebrates New Water Stewardship Certifications on World Water Day
Published: 2022-03-22 (Crawled : 12:00) - biospace.com/
ECL | News | $219.66 0.16% 0.0% 720K
|
Process Industries
|
| O: 2.74%
H: 1.92%
C: 0.55%
day
Ortho Dermatologics Will Present New Data at the 2022 American Academy of Dermatology Annual Meeting
Published: 2022-03-22 (Crawled : 12:00) - biospace.com/
BHC | $8.53 0.95% 0.0% 4M
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
RadNet, Inc. to Present at the Sidoti & Company Spring 2022 Virtual Investor Conference on Thursday, March 24th
Published: 2022-03-22 (Crawled : 12:00) - biospace.com/
RDNT | News | $48.79 2.39% 2.34% 350K
|
Health Services
|
| O: 0.31%
H: 3.0%
C: 1.52%
conference
Pyxis Oncology to Host Corporate Update Conference Call and Webcast on March 29, 2022
Published: 2022-03-22 (Crawled : 12:00) - biospace.com/
PYXS | $4.48 -1.1% -1.12% 380K
|
Professional, Scientific, and T...
|
| O: -0.75%
H: 0.0%
C: -7.34%
conference
Sage Therapeutics to Present at 2022 Stifel CNS Days
Published: 2022-03-22 (Crawled : 12:00) - biospace.com/
SAGE | $12.94 0.39% 0.39% 810K
|
Health Technology
|
| O: 0.15%
H: 3.9%
C: 3.27%
therapeutics
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-22 (Crawled : 12:00) - biospace.com/
CYCC | $1.805 3.14% 3.05% 28K
|
Health Technology
|
| O: -0.92%
H: 4.97%
C: 1.86%
results
Infinity Pharmaceuticals Announces the Date of Its Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast
Published: 2022-03-22 (Crawled : 12:00) - biospace.com/
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: 0.78%
H: 7.0%
C: 5.0%
conference results
2seventy bio Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Progress
Published: 2022-03-22 (Crawled : 12:00) - biospace.com/
TSVT | $4.63 -0.43% -0.43% 290K
|
|
| O: 0.12%
H: 7.11%
C: 5.15%
results
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-22 (Crawled : 12:00) - biospace.com/
SCPH | $4.6 0.66% 0.65% 85K
|
Health Technology
|
| O: -2.91%
H: 8.38%
C: 7.78%
results
AlloVir Initiates Global Phase 3 Registrational Study of Posoleucel for Prevention of Life-Threatening Viral Infections from Six Common Viruses in High-Risk, Allogeneic Hematopoietic Cell Transplant Patients
Published: 2022-03-22 (Crawled : 12:00) - biospace.com/
ALVR | $0.7952 4.22% 4.05% 280K
|
Health Technology
|
| O: 0.0%
H: 8.83%
C: 7.25%
phase 3 infections
Systematic Review and Meta-Analysis of Real-World Observational Studies Provide Additional Evidence of Effectiveness of PREVYMIS™ in Preventing Cytomegalovirus Infection and Disease in Adults Undergoing Allogeneic HCT
Published: 2022-03-22 (Crawled : 11:00) - biospace.com/
MRK | $126.88 -0.05% -0.13% 7.5M
|
Health Technology
|
| O: 0.27%
H: 0.64%
C: 0.04%
disease infection infections
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.